SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Vazirani Asset Management LLC

CIK 0001716476 · 1540 BROADWAY, SUITE 1600, NEW YORK, NY, 10036 · 646-504-4181

Reported Value
$53M
Q1 2023
Positions
17
Filings on Record
18
2019–present window
Filed
May 15, 2023
original filing

Summary

Vazirani Asset Management LLC reported $53M in U.S.-listed holdings across 17 positions for Q1 2023.

Its largest position, Horizon Therapeutics Pub L, represents 16.5% of the portfolio.

Compared with Q4 2022, the fund opened 9 new positions and exited 16.

Portfolio Metrics

Turnover
+64.1%
vs prior filed quarter
Top-10 Concentration
+86.7%
share of reported value
Largest Position
+16.5%
Horizon Therapeutics Pub L
New / Exited
9 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $87MQ4 ’21Q1 ’22: $116MQ2 ’22: $77MQ3 ’22: $93MQ3 ’22Q4 ’22: $59MQ1 ’23: $53MQ2 ’23: $59MQ2 ’23Q3 ’23: $65MQ4 ’23: $24MQ1 ’24: $36MQ1 ’24Q2 ’24: $47MQ3 ’24: $56MQ4 ’24: $32MQ4 ’24Q1 ’25: $27MQ2 ’25: $26MQ3 ’25: $28MQ3 ’25Q4 ’25: $16MQ1 ’26: $43Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 74.8%Other: 24.5%ADR: 0.6%
  • Common Stock · 74.8% · $40M
  • Other · 24.5% · $13M
  • ADR · 0.6% · $327,600

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
UNIVAR SOLUTIONS INCNEW+175.0K175.0K+$6M$6M
ALBERTSONS COS INCNEW+204.5K204.5K+$4M$4M
APOLLO ENDOSURGERY INCNEW+425.0K425.0K+$4M$4M
AEROJET ROCKETDYNE HLDGS INCNEW+60.0K60.0K+$3M$3M
LIFE STORAGE INCNEW+20.0K20.0K+$3M$3M
PROVENTION BIO INCNEW+80.0K80.0K+$2M$2M
NUVASIVE INCNEW+32.8K32.8K+$1M$1M
QUALTRICS INTL INCNEW+75.0K75.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

17 positions
#IssuerClass% PortfolioValueShares
1HORIZON THERAPEUTICS PUB LSHS16.51%$9M80.0K
2UNIVAR SOLUTIONS INCCOM11.59%$6M175.0K
3ACTIVISION BLIZZARD INCCOM10.52%$6M65.0K
4ALBERTSONS COS INCCOMMON STOCK8.03%$4M204.5K
5TSEMTOWER SEMICONDUCTOR LTDhistory →SHS NEW8.03%$4M100.0K
6APOLLO ENDOSURGERY INCCOM7.97%$4M425.0K
7MONEYGRAM INTL INCCOM NEW7.86%$4M399.0K
8AEROJET ROCKETDYNE HLDGS INCCOM6.37%$3M60.0K
9LIFE STORAGE INCCOM4.96%$3M20.0K
10MAXAR TECHNOLOGIES INCCOM4.83%$3M50.0K
11PROVENTION BIO INCCOM3.65%$2M80.0K
12FHNFIRST HORIZON CORPORATIONhistory →COM3.36%$2M100.0K
13NUVASIVE INCCOM2.56%$1M32.8K
14QUALTRICS INTL INCCOM CL A2.53%$1M75.0K
15SIMOSILICON MOTION TECHNOLOGY COSPONSORED ADR0.62%$327,6005.0K
16SRGSERITAGE GROWTH PPTYSCL A0.37%$196,75025.0K
17NATIONAL INSTRS CORPCOM0.25%$131,25025.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$43M20May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$16M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$28M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$26M17Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$27M15May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$32M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$56M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$47M25Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$36M18May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$24M22Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$65M26Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$59M28Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$53M17May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$59M24Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$93M37Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$77M30Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$116M57May 5, 202213F-HRchanges · EDGAR ↗
Q4 2021$87M51Feb 3, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.